1. Home
  2. FOLD vs ABR Comparison

FOLD vs ABR Comparison

Compare FOLD & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • ABR
  • Stock Information
  • Founded
  • FOLD 2002
  • ABR 2003
  • Country
  • FOLD United States
  • ABR United States
  • Employees
  • FOLD N/A
  • ABR N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • ABR Real Estate Investment Trusts
  • Sector
  • FOLD Health Care
  • ABR Real Estate
  • Exchange
  • FOLD Nasdaq
  • ABR Nasdaq
  • Market Cap
  • FOLD 2.8B
  • ABR 2.6B
  • IPO Year
  • FOLD 2007
  • ABR 2004
  • Fundamental
  • Price
  • FOLD $9.58
  • ABR $13.55
  • Analyst Decision
  • FOLD Strong Buy
  • ABR Hold
  • Analyst Count
  • FOLD 8
  • ABR 6
  • Target Price
  • FOLD $17.00
  • ABR $14.00
  • AVG Volume (30 Days)
  • FOLD 2.1M
  • ABR 2.2M
  • Earning Date
  • FOLD 02-26-2025
  • ABR 02-14-2025
  • Dividend Yield
  • FOLD N/A
  • ABR 12.65%
  • EPS Growth
  • FOLD N/A
  • ABR N/A
  • EPS
  • FOLD N/A
  • ABR 1.35
  • Revenue
  • FOLD $493,671,000.00
  • ABR $650,354,000.00
  • Revenue This Year
  • FOLD $34.33
  • ABR N/A
  • Revenue Next Year
  • FOLD $21.70
  • ABR N/A
  • P/E Ratio
  • FOLD N/A
  • ABR $10.06
  • Revenue Growth
  • FOLD 32.58
  • ABR N/A
  • 52 Week Low
  • FOLD $8.79
  • ABR $11.92
  • 52 Week High
  • FOLD $14.03
  • ABR $15.94
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 50.06
  • ABR 43.32
  • Support Level
  • FOLD $8.79
  • ABR $12.71
  • Resistance Level
  • FOLD $9.63
  • ABR $13.94
  • Average True Range (ATR)
  • FOLD 0.29
  • ABR 0.30
  • MACD
  • FOLD 0.05
  • ABR 0.04
  • Stochastic Oscillator
  • FOLD 90.48
  • ABR 59.09

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

Share on Social Networks: